kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Cynomolgus / Rhesus macaque IL-4 R alpha / CD124 Protein, 50 µg  

Recombinant Cynomolgus / Rhesus macaque IL-4 R alpha / CD124 Protein, 50 µg

Recombinant Cynomolgus / Rhesus macaque IL-4 R alpha / CD124 Protein, AA Met 26 - Arg 232, expressed from human 293 cells (HEK293), His Tag (MALS verified)

Recombinant cynomolgus protein, IL4R,CD124,IL4RA

More details


Availability: within 7 days

420,00 €

IL-4 is a pleiotropic cytokine produced by activated Th2 cells and mast cells, and plays a pivotal role in immune responses. The effects of IL-4 are mediated after binding to high affinity receptor complexes present on hematopoietic as well as non-hematopoietic cells. Hematopoietic cellular responses to IL-4 are mediated by a high affinity receptor complex comprised of the 140 kDa IL4Rα (CD124)subunit and the 70 kDa common cytokine γc chain (CD132). Interleukin 4 Receptor (IL4R) also known as CD124, IL4Rα and BSF receptor, is a type I cytokine receptor produced by activated Th2 cells and mast cells, and plays an important role in Th2-­biased immune responses, alternative macrophage activation, mucosal immunity, allergic inflammation, tumor progression, and atherogenesis. A soluble form of the encoded IL4R protein can be produced by an alternate splice variant or by proteolysis of the membrane-bound protein, and this soluble form can inhibit IL4-mediated cell proliferation and IL5 upregulation by T-cells. IL4R can alternatively associate with IL­13Ra1 to form the type II receptor which is responsive to both IL­4 and IL­13. Interleukin-4 receptor has been shown to interact with SHC1.

Recombinant Cynomolgus / Rhesus macaque IL-4 R alpha, His Tag (ILR-C52H8) is expressed from human 293 cells (HEK293). It contains AA Met 26 - Arg 232 (Accession # G7Q0S7). In the region Met 26 - Arg 232, the AA sequence of Cynomolgus and Rhesus macaque IL-4 R alpha are homologus.
Predicted N-terminus: Met 26

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 25.6 kDa. The protein migrates as 40-55 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Less than 1.0 EU per μg by the LAL method.

>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

See Certificate of Analysis for reconstitution instructions and specific concentrations.

Please refer to product data sheet.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution

Clinical and Translational Updates

(1) "Resveratrol and ω-3 PUFAs Promote Human Macrophage Differentiation and Function"
Schwager, Bompard, Raederstorff et al
Biomedicines (2022) 10 (7)
(2) "Protective effects of glaucocalyxin A on the airway of asthmatic mice"
Chen, Piao, Song et al
Open Med (Wars) (2022) 17 (1), 1158-1171
(3) "Sanguinarine ameliorates DSS induced ulcerative colitis by inhibiting NLRP3 inflammasome activation and modulating intestinal microbiota in C57BL/6 mice"
Li, Wu, Wang et al
Phytomedicine (2022) 104, 154321
Showing 1-3 of 1023 papers.